Results 121 to 130 of about 5,648,222 (168)

Advancements in the Treatment of Multiple Myeloma. [PDF]

Cureus
Zavaleta-Monestel E, Quesada-Villaseñor R, Barrantes-López M, Arguedas-Chacón S, Campos-Hernández J, Rojas-Chinchilla C, García-Montero J, Castro-Ulloa J, Anchía-Alfaro A, Montenegro-Chaves JR.   +9 more
europepmc   +1 more source

Erratum: Dual CARM1-and IKZF3-targeting: A novel approach to multiple myeloma therapy. [PDF]

Mol Ther Oncol
Ni W, Garg S, Chowdhury B, Sattler M, Sanchez D, Meng C, Akatsu T, Donovan KA, Qi J, Wang MY, Starnbach CA, Liu X, Guzman MT, Teh WP, Stone R, Griffin JD, Buhrlage S, Weisberg E.   +17 more
europepmc   +1 more source

Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: Phase 2 trial results [PDF]

, 2018
et al,, Stockerl-Goldstein, Keith E, Vij, Ravi   +2 more
core   +1 more source

Correction to "Weight Loss and Dysgeusia in Relapsed/Refractory Multiple Myeloma Patients Treated With Talquetamab". [PDF]

EJHaem
europepmc   +1 more source

CD44-downregulation in multiple myeloma inhibits cytoskeleton rearrangement through actin depolymerization. [PDF]

Clin Exp Med
Wang Z, Guo Y, Yang C, Liang H, Zhou J, Huang L, Xu Y, Xue L.   +7 more
europepmc   +1 more source

Adherence to Multidisciplinary Tumor Board Recommendations in Patients with Multiple Myeloma. [PDF]

Cancers (Basel)
Gennheimer V, Akhoundova D, Hoffmann M, Jeker B, Banz Y, Bacher U, Pabst T.   +6 more
europepmc   +1 more source

T-Cell Engagers In Multiple Myeloma: A Clinical Review. [PDF]

Blood Lymphat Cancer
Al-Jarrad A, Alouch SS, Chawla Y, Gonsalves WI.   +3 more
europepmc   +1 more source